These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
117 related items for PubMed ID: 8750274
1. Specific T and B cell immunity to measles after allogeneic and autologous bone marrow transplantation. Pauksen K, Linde A, Ljungman P, Bolme P, Lönnerholm G, Oberg G, Sjölin J. Bone Marrow Transplant; 1995 Dec; 16(6):807-13. PubMed ID: 8750274 [Abstract] [Full Text] [Related]
2. Influence of the specific T cell response on seroconversion after measles vaccination in autologous bone marrow transplant patients. Pauksen K, Linde A, Lönnerholm G, Ljungman P, Sjölin J. Bone Marrow Transplant; 1996 Nov; 18(5):969-73. PubMed ID: 8932853 [Abstract] [Full Text] [Related]
3. Th1 and Th2 cytokine responses after measles antigen stimulation in vitro in bone marrow transplant patients: response to measles vaccination. Pauksen K, Sjölin J, Linde A, Alm G, Andersson B, Lönnerholm G, Ljungman P. Bone Marrow Transplant; 1997 Aug; 20(4):317-23. PubMed ID: 9285547 [Abstract] [Full Text] [Related]
5. Humoral immunodeficiency in patients after bone marrow transplantation. Körholz D, Kunst D, Hempel L, Söhngen D, Heyll A, Mauz-Körholz C, Zintl F, Burdach S. Bone Marrow Transplant; 1996 Dec; 18(6):1123-30. PubMed ID: 8971382 [Abstract] [Full Text] [Related]
6. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)]. Badell I, Ortega JJ, Muñoz A, Bureo E, Madero L, Olivé T, Cubells J, Maldonado MS, Baro J, Díaz MA. Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349 [Abstract] [Full Text] [Related]
7. Tetanus immunity in autologous bone marrow and blood stem cell transplant recipients. Hammarström V, Pauksen K, Björkstrand B, Simonsson B, Oberg G, Ljungman P. Bone Marrow Transplant; 1998 Jul; 22(1):67-71. PubMed ID: 9678798 [Abstract] [Full Text] [Related]
8. Retrospective evaluation of autologous bone marrow transplantation vs allogeneic bone marrow transplantation from an HLA identical related donor in acute myelocytic leukemia. A study of the European Cooperative Group for Blood and Marrow Transplantation (EBMT). Gorin NC, Labopin M, Fouillard L, Meloni G, Frassoni F, Iriondo A, Brunet Mauri S, Goldstone AH, Harousseau JL, Reiffers J, Esperou-Bourdeau H, Gluckman E. Bone Marrow Transplant; 1996 Jul; 18(1):111-7. PubMed ID: 8832003 [Abstract] [Full Text] [Related]
9. Loss of seroreactivity against human papillomavirus (HPV) in bone marrow transplant recipients. Lewensohn-Fuchs I, Ljungman P, Kjerrström A, Ringdén O, Dalianis T. Bone Marrow Transplant; 1996 Aug; 18(2):333-7. PubMed ID: 8864443 [Abstract] [Full Text] [Related]
10. Early measles vaccination in bone marrow transplant recipients. Machado CM, de Souza VA, Sumita LM, da Rocha IF, Dulley FL, Pannuti CS. Bone Marrow Transplant; 2005 Apr; 35(8):787-91. PubMed ID: 15750610 [Abstract] [Full Text] [Related]
11. Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease. Ljungman P, Aschan J, Barkholt L, Broliden PA, Gustafsson B, Lewensohn-Fuchs I, Löfgren C, Winiarski J, Ringdén O. Bone Marrow Transplant; 2004 Oct; 34(7):589-93. PubMed ID: 15300234 [Abstract] [Full Text] [Related]
12. Immune recovery following bone marrow transplantation. Schwenke H, Leiblein S, Pönisch W, Kubel M, Helbig W. Folia Haematol Int Mag Klin Morphol Blutforsch; 1989 Oct; 116(3-4):509-18. PubMed ID: 2480300 [Abstract] [Full Text] [Related]
13. Immune reconstitution after purified autologous and allogeneic blood stem cell transplantation compared with unmanipulated bone marrow transplantation in children. Schwinger W, Weber-Mzell D, Zois B, Rojacher T, Benesch M, Lackner H, Dornbusch HJ, Sovinz P, Moser A, Lanzer G, Schauenstein K, Ofner P, Handgretinger R, Urban C. Br J Haematol; 2006 Oct; 135(1):76-84. PubMed ID: 16925797 [Abstract] [Full Text] [Related]
14. Antibody responses to vaccinations given within the first two years after transplant are similar between autologous peripheral blood stem cell and bone marrow transplant recipients. Gandhi MK, Egner W, Sizer L, Inman I, Zambon M, Craig JI, Marcus RE. Bone Marrow Transplant; 2001 Oct; 28(8):775-81. PubMed ID: 11781630 [Abstract] [Full Text] [Related]
15. Terminal deoxynucleotidyl transferase-positive cells in trephine biopsies following bone marrow or peripheral stem cell transplantation reflect vigorous B-cell generation. Wolf E, Harms H, Winkler J, Reulbach U, Kirchner T, Niedobitek G, Baumann I. Histopathology; 2005 Apr; 46(4):442-50. PubMed ID: 15810956 [Abstract] [Full Text] [Related]
16. Successful immunization of autologous bone marrow transplantation recipients against hepatitis B virus by active vaccination. Nagler A, Ilan Y, Adler R, Or R, Naparstek E, Shouval D, Slavin S. Bone Marrow Transplant; 1995 Mar; 15(3):475-8. PubMed ID: 7599575 [Abstract] [Full Text] [Related]
17. Immunogenicity of aerosol measles vaccine given as the primary measles immunization to nine-month-old Mexican children. Wong-Chew RM, Islas-Romero R, García-García Mde L, Beeler JA, Audet S, Santos-Preciado JI, Gans H, Lew-Yasukawa L, Maldonado YA, Arvin AM, Valdespino-Gómez JL. Vaccine; 2006 Jan 30; 24(5):683-90. PubMed ID: 16154241 [Abstract] [Full Text] [Related]
18. Immune status and the immune response to hepatitis B virus vaccine in thalassemic patients after allogeneic bone marrow transplantation. Li Volti S, Di Gregorio F, Romeo MA, Cannella A, Pizzarelli G, Sciacca A, Russo G. Bone Marrow Transplant; 1997 Jan 30; 19(2):157-60. PubMed ID: 9116613 [Abstract] [Full Text] [Related]
19. Decrease in measles virus-specific CD4 T cell memory in vaccinated subjects. Naniche D, Garenne M, Rae C, Manchester M, Buchta R, Brodine SK, Oldstone MB. J Infect Dis; 2004 Oct 15; 190(8):1387-95. PubMed ID: 15378430 [Abstract] [Full Text] [Related]
20. Clinical outcome following autologous and allogeneic blood and marrow transplantation for relapsed diffuse large-cell non-Hodgkin's lymphoma. Aksentijevich I, Jones RJ, Ambinder RF, Garrett-Mayer E, Flinn IW. Biol Blood Marrow Transplant; 2006 Sep 15; 12(9):965-72. PubMed ID: 16920563 [Abstract] [Full Text] [Related] Page: [Next] [New Search]